Compounds > glucuronic acid
Page last updated: 2024-08-24

glucuronic acid and Brain Neoplasms

glucuronic acid has been researched along with Brain Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, WY; Cheng, FY; Su, CH; Tomanek, B; Tsai, CY1
Dai, X; Lan, Q; Ma, C; Xu, T1
Baek, MJ; Chae, KS; Chang, Y; Choi, ES; Jung, JC; Kim, JH; Kim, TJ; Lee, GH; Park, JY; Woo, S1
Baltes, S; Brinker, T; Geigle, P; Glage, S; Lewis, AL; Mertens, P1
de Boer, JF; de Haan, BJ; de Vos, P; Helfrich, W; Kuijlen, JM; Mooij, JJ; Samplonius, D1
Bergers, G; Hanahan, D1
Bjerkvig, R; Enger, PO; Haraldseth, O; Hjelstuen, MH; Mahesparan, R; Olsen, BR; Read, TA; Sorensen, DR; Timpl, R1
Bjerkvig, R; Enger, PO; Visted, T1
Bjerkvig, R; Farhadi, M; Huszthy, PC; Olsen, BR; Read, TA; Rokstad, AM; Vajkoczy, P1

Reviews

1 review(s) available for glucuronic acid and Brain Neoplasms

ArticleYear
Cell encapsulation technology as a therapeutic strategy for CNS malignancies.
    Neuro-oncology, 2001, Volume: 3, Issue:3

    Topics: Alginates; Biocompatible Materials; Bioreactors; Brain Neoplasms; Cerebral Ventricles; Delayed-Action Preparations; Drug Delivery Systems; Genetic Therapy; Glucuronic Acid; Hexuronic Acids; Humans; Recombinant Proteins

2001

Other Studies

8 other study(ies) available for glucuronic acid and Brain Neoplasms

ArticleYear
Evaluation of blood-brain barrier-stealth nanocomposites for in situ glioblastoma theranostics applications.
    Nanoscale, 2016, Apr-21, Volume: 8, Issue:15

    Topics: Alginates; Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Doxorubicin; Drug Carriers; Glioblastoma; Glucuronic Acid; Hexuronic Acids; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Nanocomposites; Neuroimaging; Theranostic Nanomedicine

2016
3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility.
    Biofabrication, 2016, 10-11, Volume: 8, Issue:4

    Topics: Alginates; Antineoplastic Agents, Alkylating; Bioprinting; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Fibrinogen; Gelatin; Glioma; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Models, Biological; Neoplastic Stem Cells; Porosity; Printing, Three-Dimensional; Temozolomide; Tissue Scaffolds; Vascular Endothelial Growth Factor A

2016
Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    ACS nano, 2009, Nov-24, Volume: 3, Issue:11

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Gadolinium; Glucuronic Acid; Humans; Injections; Magnetic Resonance Imaging; Magnetics; Nanoparticles; Particle Size; Protons; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Water

2009
Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2012, Volume: 14, Issue:1

    Topics: Alginates; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Doxorubicin; Drug Delivery Systems; Female; Glioma; Glucuronic Acid; Hexuronic Acids; Irinotecan; Male; Materials Testing; Microspheres; Rats; Survival Rate; Suspensions; Tumor Burden

2012
The efficacy of alginate encapsulated CHO-K1 single chain-TRAIL producer cells in the treatment of brain tumors.
    Journal of neuro-oncology, 2006, Volume: 78, Issue:1

    Topics: Alginates; Animals; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Compounding; Female; Glucuronic Acid; Hexuronic Acids; Materials Testing; Mice; Mice, Inbred C57BL; Recombinant Fusion Proteins; Single-Chain Antibodies

2006
Cell factories for fighting cancer.
    Nature biotechnology, 2001, Volume: 19, Issue:1

    Topics: Alginates; Angiogenesis Inhibitors; Animals; Brain Neoplasms; Capsules; Cell Line; Cell Transplantation; Collagen; Endostatins; Glucuronic Acid; Hexuronic Acids; Humans; Peptide Fragments; Transfection

2001
Local endostatin treatment of gliomas administered by microencapsulated producer cells.
    Nature biotechnology, 2001, Volume: 19, Issue:1

    Topics: Alginates; Angiogenesis Inhibitors; Animals; Apoptosis; Biocompatible Materials; Brain Neoplasms; Capsules; Cell Hypoxia; Cell Line; Cell Survival; Cell Transplantation; Collagen; Endostatins; Glioma; Glucuronic Acid; Hexuronic Acids; Humans; Magnetic Resonance Imaging; Peptide Fragments; Rats; Transfection; Transplantation, Heterologous

2001
Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Cancer research, 2001, Sep-15, Volume: 61, Issue:18

    Topics: Alginates; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Division; Cell Movement; Collagen; Drug Carriers; Drug Delivery Systems; Endostatins; Female; Glioma; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Microscopy, Video; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptide Fragments; Rats; Spheroids, Cellular; Transfection; Xenograft Model Antitumor Assays

2001